Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Adalimumab> ?p ?o }
- Adalimumab abstract "Adalimumab, trade names Humira ("human monoclonal antibody in rheumatoid arthritis") and Exemptia are TNF inhibiting anti-inflammatory drug manufactured by AbbVie and Zydus Cadila respectively. Adalimumab binds to tumor necrosis factor-alpha (TNFα). TNFα normally binds to TNFα receptors, which leads to the inflammatory response of autoimmune diseases. By binding to TNFα, adalimumab reduces this inflammatory response. Adalimumab has been approved in the United States for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, moderate to severe chronic psoriasis Hidrdenitis Suppurativa and juvenile idiopathic arthritis. In rheumatoid arthritis, adalimumab has a response rate similar to methotrexate, and in combination nearly doubles the response rate of methotrexate alone.Because TNFα is part of the immune system that protects the body from infection, treatment with adalimumab may increase the risk of infections.Adalimumab was the first fully human monoclonal antibody drug approved by the FDA. It was derived from phage display, and was discovered through a collaboration between BASF Bioresearch Corporation (Worcester, Massachusetts, a unit of BASF) and Cambridge Antibody Technology as D2E7, then further manufactured at BASF Bioresearch Corporation and developed by BASF Knoll (BASF Pharma) and, ultimately, manufactured and marketed by Abbott Laboratories after the acquisition of BASF Pharma by Abbott. On January 1, 2013 Abbott split into two companies, one retaining the Abbott name and the other named AbbVie. Humira is now owned by AbbVie.Humira costs approximately $3,100 per month, like the TNF-alpha inhibitor etanercept. In 2012, Humira had $4.3 billion of sales in the US, and $9.3 billion worldwide. In December 2014, Cadila Healthcare Ltd., launched in India the first Adalimumab biosimilar, under the name Exemptia, at a price of $200 a vial. Humira's U.S. patent will expire in 2016.".
- Adalimumab atcPrefix "L04".
- Adalimumab atcSuffix "AB04".
- Adalimumab bioavailability "64.0".
- Adalimumab casNumber "331731-18-1".
- Adalimumab drugbank "DB00051".
- Adalimumab fdaUniiCode "FYS6T7F842".
- Adalimumab thumbnail Adalimumab_structure.png?width=300.
- Adalimumab wikiPageExternalLink www.drugcite.com?q=HUMIRA.
- Adalimumab wikiPageExternalLink www.exemptia.com.
- Adalimumab wikiPageExternalLink www.humira.co.nz.
- Adalimumab wikiPageExternalLink www.humira.com.
- Adalimumab wikiPageID "1829708".
- Adalimumab wikiPageLength "20865".
- Adalimumab wikiPageOutDegree "88".
- Adalimumab wikiPageRevisionID "683817370".
- Adalimumab wikiPageWikiLink AbbVie.
- Adalimumab wikiPageWikiLink Abbott_Laboratories.
- Adalimumab wikiPageWikiLink American_College_of_Rheumatology.
- Adalimumab wikiPageWikiLink Ankylosing_spondylitis.
- Adalimumab wikiPageWikiLink Anti-inflammatory.
- Adalimumab wikiPageWikiLink Autoimmune_disease.
- Adalimumab wikiPageWikiLink BASF.
- Adalimumab wikiPageWikiLink Black_box_warning.
- Adalimumab wikiPageWikiLink Boxed_warning.
- Adalimumab wikiPageWikiLink Cadila_Healthcare.
- Adalimumab wikiPageWikiLink Cambridge_Antibody_Technology.
- Adalimumab wikiPageWikiLink Cancer.
- Adalimumab wikiPageWikiLink Category:Immunosuppressants.
- Adalimumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Adalimumab wikiPageWikiLink Category:TNF_inhibitors.
- Adalimumab wikiPageWikiLink Central_nervous_system.
- Adalimumab wikiPageWikiLink Certolizumab_pegol.
- Adalimumab wikiPageWikiLink Chimera_(protein).
- Adalimumab wikiPageWikiLink Crohns_disease.
- Adalimumab wikiPageWikiLink Demyelinating.
- Adalimumab wikiPageWikiLink Drug.
- Adalimumab wikiPageWikiLink Etanercept.
- Adalimumab wikiPageWikiLink Food_and_Drug_Administration.
- Adalimumab wikiPageWikiLink Fusion_protein.
- Adalimumab wikiPageWikiLink Golimumab.
- Adalimumab wikiPageWikiLink High_Court_of_Justice.
- Adalimumab wikiPageWikiLink Hugh_Laddie.
- Adalimumab wikiPageWikiLink IMS_Health.
- Adalimumab wikiPageWikiLink Infection.
- Adalimumab wikiPageWikiLink Infliximab.
- Adalimumab wikiPageWikiLink Juvenile_idiopathic_arthritis.
- Adalimumab wikiPageWikiLink Light_therapy.
- Adalimumab wikiPageWikiLink Liver.
- Adalimumab wikiPageWikiLink London.
- Adalimumab wikiPageWikiLink Lymphoma.
- Adalimumab wikiPageWikiLink Medical_Research_Council_(UK).
- Adalimumab wikiPageWikiLink Medical_Research_Council_(United_Kingdom).
- Adalimumab wikiPageWikiLink Methotrexate.
- Adalimumab wikiPageWikiLink Monoclonal_antibody.
- Adalimumab wikiPageWikiLink Myelin.
- Adalimumab wikiPageWikiLink Oral_administration.
- Adalimumab wikiPageWikiLink Per_os.
- Adalimumab wikiPageWikiLink Phage_display.
- Adalimumab wikiPageWikiLink Phototherapy.
- Adalimumab wikiPageWikiLink Plaque_psoriasis.
- Adalimumab wikiPageWikiLink Psoriasis.
- Adalimumab wikiPageWikiLink Psoriatic_arthritis.
- Adalimumab wikiPageWikiLink Rheumatoid_arthritis.
- Adalimumab wikiPageWikiLink Subcutaneous_injection.
- Adalimumab wikiPageWikiLink TNF.
- Adalimumab wikiPageWikiLink TNF_alpha.
- Adalimumab wikiPageWikiLink TNF_inhibitor.
- Adalimumab wikiPageWikiLink Trade_name.
- Adalimumab wikiPageWikiLink Trade_names.
- Adalimumab wikiPageWikiLink Tuberculosis.
- Adalimumab wikiPageWikiLink Tumor_necrosis_factor-alpha.
- Adalimumab wikiPageWikiLink Tumor_necrosis_factor_alpha.
- Adalimumab wikiPageWikiLink Tumor_necrosis_factors.
- Adalimumab wikiPageWikiLink UK.
- Adalimumab wikiPageWikiLink Ulcerative_colitis.
- Adalimumab wikiPageWikiLink United_Kingdom.
- Adalimumab wikiPageWikiLink United_States.
- Adalimumab wikiPageWikiLink United_States_Court_of_Appeals_for_the_Federal_Circuit.
- Adalimumab wikiPageWikiLink Zydus_Cadila.
- Adalimumab wikiPageWikiLink File:Components_of_a_Adalimumab-Humira_pen_-_annotated.jpg.
- Adalimumab wikiPageWikiLinkText "''ada''limumab".
- Adalimumab wikiPageWikiLinkText "Adalimumab".
- Adalimumab wikiPageWikiLinkText "Humira".
- Adalimumab wikiPageWikiLinkText "adalimumab".
- Adalimumab wikiPageWikiLinkText "adalimumab-Humira".
- Adalimumab wikiPageWikiLinkText "royalties payable on Adalimumab sales".
- Adalimumab atcPrefix "L04".
- Adalimumab atcSuffix "AB04".
- Adalimumab bioavailability "64".
- Adalimumab c "6428".
- Adalimumab casNumber "331731".
- Adalimumab chembl "1201580".
- Adalimumab chemspiderid "NA".
- Adalimumab drugbank "DB00051".
- Adalimumab eliminationHalfLife "10".
- Adalimumab h "9912".
- Adalimumab hasPhotoCollection Adalimumab.
- Adalimumab kegg "D02597".
- Adalimumab legalUk "POM".